Camp4 Therapeutics Corp financial data

Symbol
CAMP on Nasdaq
Location
One Kendall Square, Building 1400 West, 3 Rd Floor, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 757 %
Debt-to-equity 30.6 %
Return On Equity -100 % -375%
Return On Assets -76.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.9M shares
Common Stock, Shares, Outstanding 46.9M shares +4560%
Common Stock, Value, Issued 5K USD +150%
Weighted Average Number of Shares Outstanding, Basic 27.3M shares +4793%
Weighted Average Number of Shares Outstanding, Diluted 27.3M shares +4793%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 795K USD
Research and Development Expense 39.8M USD -3.57%
General and Administrative Expense 17.3M USD +20.5%
Operating Income (Loss) -53.8M USD -1%
Nonoperating Income (Expense) 416K USD -4625%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -53.4M USD -3.68%
Earnings Per Share, Basic 63 USD/shares +97.7%
Earnings Per Share, Diluted 63 USD/shares +97.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 75.3M USD +2877%
Other Assets, Current 204K USD -29.7%
Assets, Current 77.7M USD +1312%
Property, Plant and Equipment, Net 2.9M USD
Operating Lease, Right-of-Use Asset 4.08M USD -37.1%
Assets 86.4M USD +304%
Accounts Payable, Current 585K USD -84.9%
Employee-related Liabilities, Current 2.05M USD +20.4%
Accrued Liabilities, Current 4.07M USD +10.6%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 7.9M USD -33.2%
Operating Lease, Liability, Noncurrent 3.05M USD -51.5%
Other Liabilities, Noncurrent 2K USD
Liabilities 27.7M USD +52.4%
Retained Earnings (Accumulated Deficit) -252M USD -26.9%
Stockholders' Equity Attributable to Parent 58.7M USD
Liabilities and Equity 86.4M USD +304%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.3M USD -28.2%
Net Cash Provided by (Used in) Financing Activities -151K USD +25.2%
Net Cash Provided by (Used in) Investing Activities -279K USD -1760%
Common Stock, Shares Authorized 175M shares -16.7%
Common Stock, Shares, Issued 46.9M shares +4423%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.7M USD -29.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.9M USD +1752%
Deferred Tax Assets, Valuation Allowance 64.9M USD +30.9%
Deferred Tax Assets, Gross 66.6M USD +28.7%
Operating Lease, Liability 6.27M USD -31.8%
Payments to Acquire Property, Plant, and Equipment 279K USD +1760%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -53.4M USD -12%
Lessee, Operating Lease, Liability, to be Paid 6.68M USD -33.9%
Property, Plant and Equipment, Gross 10.5M USD
Operating Lease, Liability, Current 3.23M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.98M USD -44.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.56M USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 407K USD -55.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 264K USD -86.7%
Deferred Tax Assets, Operating Loss Carryforwards 27.7M USD +46.1%
Preferred Stock, Shares Authorized 25M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 263K USD
Operating Lease, Payments 3.45M USD +13.8%
Additional Paid in Capital 311M USD +686%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 421K USD -3.44%
Share-based Payment Arrangement, Expense 3.65M USD -38.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares